{"id":40155,"date":"2021-03-12T07:45:45","date_gmt":"2021-03-12T07:45:45","guid":{"rendered":"https:\/\/i-base.info\/htb\/?p=40155"},"modified":"2021-03-29T18:18:36","modified_gmt":"2021-03-29T18:18:36","slug":"28th-conference-on-retroviruses-and-opportunistic-infections-croi-2021","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/40155","title":{"rendered":"28th Conference on Retroviruses and Opportunistic Infections (CROI 2021)"},"content":{"rendered":"<p class=\"HTBsubhead3authorcredit\"><strong><span lang=\"EN-US\">6 \u2013 10 March 2021, virtual conference<\/span><\/strong><\/p>\n<h2><strong><span lang=\"EN-US\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-medium wp-image-40209\" src=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2021\/03\/CROI-2021-logo-213x300.png\" alt=\"\" width=\"213\" height=\"300\" srcset=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2021\/03\/CROI-2021-logo-213x300.png 213w, https:\/\/i-base.info\/htb\/wp-content\/uploads\/2021\/03\/CROI-2021-logo.png 371w\" sizes=\"auto, (max-width: 213px) 100vw, 213px\" \/><\/span><\/strong>Introduction<\/h2>\n<div>\n<p class=\"HTBBODYtext\"><b><span lang=\"EN-US\">For many people, CROI 2021 this anniversary marks the first recognition of the potential global risk from COVID-19: the start of a difficult year, unimaginable before. <\/span><\/b><\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\"><b><span lang=\"EN-US\">A year ago, as delegates were either arriving in Boston or preparing to fly, CROI rapidly adapted a few days before the meeting was due to start, to become the first large virtual conference.<\/span><\/b><\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">This year CROI was planned as a fully virtual meeting, and included approximately 3500 registered delegates.<\/span><\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">The programme was exciting as it always is, with a significant and appropriate focus on COVID-19, including first presentations for new treatments. It also included important presentations on new and pipeline HIV drugs for both prevention and treatment, many using long-acting formulations.<\/span><\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">The virtual meeting retained the regular CROI format and included the options to discuss presentations using chat and Q&amp;A options to ask questions about oral presentations in real time.<\/span><\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">One advance \u2013 a good one \u2013 is a new format for the posters. Rather than 1000+ posters, available as PDF files, the virtual meeting has edited posters to around six summary slides with a 4-minute narrative by the presenter (now called a \u2018science spotlight\u2019). Each virtual poster also allows an online dialogue with the presenter that remains online for general viewing and is a pretty good way to retain something of the direct dialogue that we\u00a0<\/span><\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">Another change though was more difficult was suggesting that a 6-month pay wall before the presentations become open access. CROI has always developed a leading role in democratising access to the latest medical research and at the start of the conference even the abstract book was planned to need a paid subscription. This is disappointing and will hopefully be rethought.<\/span><\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">At least one community sign on letter with more than 200 organisations and individuals has already asked for the whole meeting to have a much shorter window to open access. As a result, the abstract book is now available:<br \/>\n<a href=\"https:\/\/www.croiconference.org\/vcroi-2021\">https:\/\/www.croiconference.org\/vcroi-2021<\/a><\/span><\/p>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">Currently, content on the main conference website is only accessible to delegates, although this decision might be reviewed.<br \/>\n<\/span><a href=\"http:\/\/www.vcroi2021.org\"><span lang=\"EN-US\">www.vcroi2021.org<\/span><\/a><\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">Even if all links are not yet active to non-delegates, i-Base reports will still include hyperlinks to the abstract, webinars and full presentations. We apologise for this and hope CROI reconsiders their decision after the meeting.<\/span><\/p>\n<\/div>\n<p class=\"HTBBODYtext\">Reports in HTB will also therefore focus on shorter articles to emphasise summary conclusions,\u00a0with comment, as a way to cover a wider range of presentations.<\/p>\n<p class=\"HTBBODYtext\">Early reports will be added to this page as they become available.<\/p>\n<ul>\n<li><a href=\"https:\/\/i-base.info\/htb\/40290\">CROI 2021: First results against MDR HIV using capsid inhibitor lenacapavir: potential for six-monthly ART and PrEP<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/40188\">CROI 2021: Community call highlights CROI 6-month pay wall rather than usual open access<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/40180\">CROI 2021: Once-daily GSK254 maturation inhibitor as treatment for HIV multidrug resistance<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/40165\">CROI 2021: Dolutegravir with recycled tenofovir and lamivudine performs well second-line: primary results from the NADIA trial<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/40142\">CROI 2021: Islatravir dosing for once-monthly and annual PrEP: if effective this could end HIV<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/40158\">CROI 2021: Dosing for once-weekly oral ART: islatravir plus MK-8507 studies due to start in 2021<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/40131\">CROI 2021: Urgency of global access to vaccines, the potential of mAbs and the lessons learned from HIV<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/40151\">CROI 2021: HIV capsid uncoats in the CD4 nucleus rather than the cytoplasm \u2013 viral lifecycle updated\u2026<\/a><\/li>\n<\/ul>\n<p><em>This article was first posted on 6 March and is updated as information becomes available.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Reports from CROI 2021&#8230;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[12,307],"class_list":["post-40155","post","type-post","status-publish","format-standard","hentry","category-conference-reports","tag-conference-index","tag-croi-2021-virtual"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/40155","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=40155"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/40155\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=40155"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=40155"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=40155"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}